Long QT syndromes and torsade de pointes

[1]  S. Priori,et al.  The Long QT Syndrome , 1997, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  M. Keating,et al.  MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.

[3]  H. Crijns,et al.  QT lengthening and life-threatening arrhythmias associated with fexofenadine , 1999, The Lancet.

[4]  S. Priori,et al.  Low penetrance in the long-QT syndrome: clinical impact. , 1999, Circulation.

[5]  R. Hauer,et al.  Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management , 2022 .

[6]  C. Antzelevitch,et al.  Sodium Pentobarbital Reduces Transmural Dispersion of Repolarization and Prevents Torsades de Pointes in Models of Acquired and Congenital Long QT Syndrome , 1999, Journal of cardiovascular electrophysiology.

[7]  R. Hauer,et al.  Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). , 1999, Journal of the American College of Cardiology.

[8]  C Antzelevitch,et al.  Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. , 1998, Circulation.

[9]  S. Priori,et al.  Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. , 1998, The New England journal of medicine.

[10]  D. Zipes,et al.  Short‐Term Rapid Ventricular Pacing Prolongs Ventricular Refractoriness in Patients , 1998, Journal of cardiovascular electrophysiology.

[11]  D. Rampe,et al.  The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. , 1998, The Journal of pharmacology and experimental therapeutics.

[12]  S. Viskin,et al.  Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy. , 1998, Progress in cardiovascular diseases.

[13]  S. Priori,et al.  A recessive variant of the Romano-Ward long-QT syndrome? , 1998, Circulation.

[14]  C. Berul,et al.  Proarrhythmia associated with cisapride in children. , 1998, Pediatrics.

[15]  D. Roden.  Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes , 1998, Pacing and clinical electrophysiology : PACE.

[16]  J. Brachmann,et al.  Electrocardiographic and Clinical Predictors of Torsades de Pointes Induced by Almokalant Infusion in Patients with Chronic Atrial Fibrillation or Flutter: A Prospective Study , 1998, Pacing and clinical electrophysiology : PACE.

[17]  J. Towbin,et al.  Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome. , 1998, Circulation.

[18]  S. Viskin,et al.  Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause prevention pacing algorithm , 1998, Heart.

[19]  B. Drolet,et al.  Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. , 1998, Circulation.

[20]  Priya D. Duggal,et al.  Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. , 1998, Circulation.

[21]  J. Brachmann,et al.  Electrocardiographic and Clinical Predictors of Torsades de Pointes Induced by Almokalant Infusion in patients With Chronic Atrial Fibrillatio and Flutter , 1998 .

[22]  Vincent Gm,et al.  The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. , 1998 .

[23]  P. Coumel,et al.  KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. , 1997, Circulation.

[24]  D. Bernstein,et al.  Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[25]  A. Moss,et al.  Electrocardiographic findings in patients with diphenhydramine overdose. , 1997, The American journal of cardiology.

[26]  D. Roden,et al.  Normalization of acquired QT prolongation in humans by intravenous potassium. , 1997, Circulation.

[27]  C Antzelevitch,et al.  Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. , 1997, Circulation.

[28]  S. Priori,et al.  Molecular Biology of the Long QT Syndrome: Impact on Management , 1997, Pacing and clinical electrophysiology : PACE.

[29]  M. Keating,et al.  Molecular basis of the long-QT syndrome associated with deafness. , 1997, The New England journal of medicine.

[30]  W. Shimizu,et al.  Early Afterdepolarizationlike Activity in Patients with Class IA Induced Long QT Syndrome and Torsades de Pointes , 1997, Pacing and clinical electrophysiology : PACE.

[31]  J. Olgin,et al.  The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies. , 1997, Current problems in cardiology.

[32]  C Antzelevitch,et al.  Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. , 1996, Journal of the American College of Cardiology.

[33]  C. January,et al.  Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole. , 1996, Journal of the American College of Cardiology.

[34]  S. Viskin,et al.  Mode of onset of torsade de pointes in congenital long QT syndrome. , 1996, Journal of the American College of Cardiology.

[35]  R Lazzara,et al.  Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. , 1996, Circulation.

[36]  J. Mason,et al.  Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. , 1996, Circulation.

[37]  M Restivo,et al.  The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Tridimensional mapping of activation and recovery patterns. , 1996, Circulation research.

[38]  D. Wysowski,et al.  Cisapride and fatal arrhythmia. , 1996, The New England journal of medicine.

[39]  S. Priori,et al.  Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. , 1996, Circulation research.

[40]  R. Benton,et al.  Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram , 1996, Clinical pharmacology and therapeutics.

[41]  V. Fuster,et al.  Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. , 1996, Circulation.

[42]  D. Roden,et al.  Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. , 1996, Circulation.

[43]  Carlo Napolitano,et al.  Erratum: Long QT syndrome patients with mutations on the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: Implications for gene-specific therapy (Circulation (1995) 92 (3381-3386)) , 1996 .

[44]  S. Priori,et al.  Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. , 1995, Circulation.

[45]  M. Lehmann,et al.  Increased Propensity of Women to Develop Torsades de Pointes During Complete Heart Block , 1995, Journal of cardiovascular electrophysiology.

[46]  Y. T. Lee,et al.  Torsade de pointes and T-wave alternans in a patient with brainstem hemorrhage. , 1995, International journal of cardiology.

[47]  A. Jonzon,et al.  Isolated congenital complete atrioventricular block in adult life. A prospective study. , 1995, Circulation.

[48]  P. Coumel,et al.  Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings. , 1995, Journal of the American College of Cardiology.

[49]  W. Shimizu,et al.  Physiological and pathological responses of TU waves to class Ia antiarrhythmic drugs. , 1995, European heart journal.

[50]  R. Platt,et al.  Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization. , 1995, Annals of epidemiology.

[51]  H. Tan,et al.  Electrophysiologic Mechanisms of the Long QT Interval Syndromes and Torsade de Pointes , 1995, Annals of Internal Medicine.

[52]  D. Roden,et al.  Block of IKs, the slow component of the delayed rectifier K+ current, by the diuretic agent indapamide in guinea pig myocytes. , 1994, Circulation research.

[53]  M. Boutjdir,et al.  Ketanserin inhibits depolarization-activated outward potassium current in rat ventricular myocytes. , 1994, Circulation research.

[54]  T Treasure,et al.  QT interval in anorexia nervosa. , 1994, British heart journal.

[55]  C Antzelevitch,et al.  Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. , 1994, Journal of the American College of Cardiology.

[56]  M. Lehmann,et al.  Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs , 1993 .

[57]  G. V. Van Hare,et al.  The Long QT Syndrome in Children An International Study of 287 Patients , 1993, Circulation.

[58]  M. Leppert,et al.  The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. , 1992, The New England journal of medicine.

[59]  R. Wesley,et al.  Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome. , 1992, American heart journal.

[60]  T. Kurita,et al.  Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes. , 1992, The American journal of cardiology.

[61]  A. Moss,et al.  Efficacy of Permanent Pacing in the Management of High‐Risk Patients With Long QT Syndrome , 1991, Circulation.

[62]  A. Moss,et al.  Left Cardiac Sympathetic Denervation in the Therapy of Congenital Long QT Syndrome: A Worldwide Report , 1991, Circulation.

[63]  C. L. Ferguson,et al.  Torsades de pointes occurring in association with terfenadine use. , 1990, JAMA.

[64]  S. Nattel,et al.  Pharmacological response of quinidine induced early afterdepolarisations in canine cardiac Purkinje fibres: insights into underlying ionic mechanisms. , 1988, Cardiovascular research.

[65]  E. Aliot,et al.  The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. , 1988, Progress in cardiovascular diseases.

[66]  E. Prystowsky,et al.  Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy. , 1988, The New England journal of medicine.

[67]  S. Cotev,et al.  Life-threatening torsade de pointes arrhythmia associated with head injury. , 1988, Neurosurgery.

[68]  D. Zipes,et al.  Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs. , 1988, Circulation.

[69]  A. Keren,et al.  Treatment of torsade de pointes with magnesium sulfate. , 1988, Circulation.

[70]  M. Eldar,et al.  Permanent cardiac pacing in patients with the long QT syndrome. , 1987, Journal of the American College of Cardiology.

[71]  A. Andreoli,et al.  Subarachnoid hemorrhage: frequency and severity of cardiac arrhythmias. A survey of 70 cases studied in the acute phase. , 1987, Stroke.

[72]  A. Moss,et al.  The long QT syndrome: a prospective international study. , 1985, Circulation.

[73]  G. Kay,et al.  Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. , 1983, Journal of the American College of Cardiology.

[74]  T. Pottecher,et al.  Prolongation of the Q-T interval and sudden cardiac arrest following right radical neck dissection. , 1983, Anesthesiology.

[75]  E. Orinius,et al.  Prodromal ventricular premature beats preceded by a diastolic wave. , 2009, Acta medica Scandinavica.

[76]  W. Roberts,et al.  Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval. , 1979, Circulation.

[77]  M. Grossman.  Cardiac arrhythmias in acute central nervous system disease. Successful management with stellate ganglion block. , 1976, Archives of internal medicine.

[78]  A. Malliani,et al.  The long Q-T syndrome. , 1975, American heart journal.